Overview

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is a human pharmacology, single-dose study to investigate the pharmacokinetics of orally administered Levetiracetam (LEV) in Japanese subjects with normal renal function and in Japanese subjects with various degrees of impaired renal function.
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
Collaborator:
Parexel
Treatments:
Etiracetam
Levetiracetam
Piracetam